Who We Are


ETERN is an Innovative Precision Oncology Company Focusing on Developing Novel Small Molecule Drugs to Inhibit “Undruggable” Targets, a Cutting-Edge and Highly Sought-After Area in Pharmaceutical Industry


“Undruggable” Targets

Science


  • Many Key Cancer Targets are "Undruggable" by the Existing Technology
  • We Develop Novel Technology for Targeting "Undruggable" Targets